XML 68 R43.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stockholders' Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Compensation Related Costs [Abstract] |
Schedule of Stockholders' Deficit | The following tables present certain information regarding our stockholders’ equity (deficit) as of September 30, 2022 and 2021:
| Nine Months Ended September 30, 2022
| Common Stock |  | Additional Paid in Capital |  | Retained Earnings (Accumulated Loss) |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
January 1, 2022 | $ | 1 |  |  | $ | 1,337 |  |  | $ | (3,158) |  |  | $ | (175) |  |  | $ | (261) |  |  | $ | 150 |  |  | $ | (2,106) |
Settlement of liability awards and other, net | — |  |  | 43 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 43 |
Vesting of RSUs, net of tax withholdings | — |  |  | (31) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (31) |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | (51) |  |  | — |  |  | — |  |  | (51) |
Stock-based compensation | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Net income | — |  |  | — |  |  | 26 |  |  | — |  |  | — |  |  | 2 |  |  | 28 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (37) |  |  | — |  |  | (37) |
March 31, 2022 | $ | 1 |  |  | $ | 1,366 |  |  | $ | (3,132) |  |  | $ | (226) |  |  | $ | (298) |  |  | $ | 152 |  |  | $ | (2,137) |
Vesting of RSUs, net of tax withholdings and other | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | (152) |  |  | — |  |  | — |  |  | (152) |
Purchase of SciPlay common stock | — |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (7) |
Stock-based compensation | — |  |  | 15 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15 |
Net income | — |  |  | — |  |  | 3,291 |  |  | — |  |  | — |  |  | 4 |  |  | 3,295 |
Other comprehensive loss(1) | — |  |  | — |  |  | — |  |  | — |  |  | (48) |  |  | — |  |  | (48) |
June 30, 2022 | $ | 1 |  |  | $ | 1,375 |  |  | $ | 159 |  |  | $ | (378) |  |  | $ | (346) |  |  | $ | 155 |  |  | $ | 966 |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (3) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |
Purchase of SciPlay common stock | — |  |  | (10) |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (11) |
Stock-based compensation | — |  |  | 14 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 14 |
Net income | — |  |  | — |  |  | 328 |  |  | — |  |  | — |  |  | 7 |  |  | 335 |
Other comprehensive loss(1) | — |  |  | — |  |  | — |  |  | — |  |  | (69) |  |  | — |  |  | (69) |
September 30, 2022 | $ | 1 |  |  | $ | 1,376 |  |  | $ | 487 |  |  | $ | (378) |  |  | $ | (415) |  |  | $ | 161 |  |  | $ | 1,232 |
(1) Includes reclassifications of $51 million and $74 million for the three and nine months ended September 30, 2022, respectively, from accumulated other comprehensive loss into income due to the sales of discontinued operations (see Note 2).
| Nine Months Ended September 30, 2021
| Common Stock |  | Additional Paid in Capital |  | Accumulated Loss |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
January 1, 2021 | $ | 1 |  |  | $ | 1,268 |  |  | $ | (3,529) |  |  | $ | (175) |  |  | $ | (218) |  |  | $ | 129 |  |  | $ | (2,524) |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (13) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (13) |
Stock-based compensation | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Net (loss) income | — |  |  | — |  |  | (15) |  |  | — |  |  | — |  |  | 6 |  |  | (9) |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 8 |  |  | — |  |  | 8 |
March 31, 2021 | $ | 1 |  |  | $ | 1,272 |  |  | $ | (3,544) |  |  | $ | (175) |  |  | $ | (210) |  |  | $ | 135 |  |  | $ | (2,521) |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |
Stock-based compensation | — |  |  | 31 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 31 |
Net income | — |  |  | — |  |  | 109 |  |  | — |  |  | — |  |  | 4 |  |  | 113 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 11 |  |  | — |  |  | 11 |
June 30, 2021 | $ | 1 |  |  | $ | 1,299 |  |  | $ | (3,435) |  |  | $ | (175) |  |  | $ | (199) |  |  | $ | 139 |  |  | $ | (2,370) |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (3) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |
Stock-based compensation | — |  |  | 22 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22 |
Net income | — |  |  | — |  |  | 182 |  |  | — |  |  | — |  |  | 5 |  |  | 187 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (27) |  |  | — |  |  | (27) |
September 30, 2021 | $ | 1 |  |  | $ | 1,318 |  |  | $ | (3,253) |  |  | $ | (175) |  |  | $ | (226) |  |  | $ | 144 |  |  | $ | (2,191) |
Schedule of Stock-based Compensation Expense Recognized | The following reflects total stock-based compensation expense recognized under all programs in our continuing operations:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Related to L&W stock options | $ | — |  |  | $ | 3 |  |  | $ | 1 |  |  | $ | 25 |
Related to L&W RSUs | 12 |  |  | 23 |  |  | 39 |  |  | 51 |
Related to SciPlay RSUs | 3 |  |  | — |  |  | 7 |  |  | 5 |
Total | $ | 15 |  |  | $ | 26 |  |  | $ | 47 |  |  | $ | 81 |
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity | A summary of the changes in RSUs outstanding under our equity-based compensation plans during the nine months ended September 30, 2022 is presented below:
| Number of Restricted Stock Units |  | Weighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2021 | 2.7 |  |  | $ | 32.03 |
Granted | 1.7 |  |  | $ | 57.26 |
Vested | (1.9) |  |  | $ | 38.75 |
Cancelled | (0.7) |  |  | $ | 37.75 |
Unvested RSUs as of September 30, 2022 | 1.8 |  |  | $ | 46.50 |

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration